Delivery Order SPE2DB22D3301-SPE2DB24FY9MC

Award Date 6/28/24
Potential Completion Date 7/22/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S for the Defense Logistics Agency (DLA). The firm-fixed-price contract has a ceiling value of $7,492.44 and a period of performance through January 22, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products, including the drug BRUKINSA 80 MG CAPSULE 120S, to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) has a ceiling value of $7,242.15 and an ultimate completion date of July 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger IDC with the DLA Troop Support Medical valued up to...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order from the Defense Logistics Agency (DLA), a Defense agency, for the supply of pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The contract has a firm fixed price of $6,370.00 and a completion date of July 23, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The $14,484.30 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of BRUKINSA 80 MG CAPSULE 120S. The firm-fixed-price delivery order, valued at $7,242.15, has an ultimate completion date of December 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of BRUKINSA 80 MG CAPSULE 120S. The $50,960.00 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through July 23, 2025. The contract is not set-aside and allows for the delivery of a variety of pharmaceutical and medical products to support military...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, to provide the drug Brukinsa 80 mg capsules to the U.S. Department of Defense's (DOD) Medical Supply Chain. The contract, valued at $7,242.15, is a Firm Fixed Price Delivery Order with a completion date of July 23, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,984.88 firm fixed-price delivery order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, with an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a specialty medication. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9MC
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order, valued at $7,242.15, has an ultimate completion date of July 22, 2024. The award is not associated with a set-aside designation.

Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/27/24, 9:27 AM